Changes in Cancer Trial Design After Initiation of Patient Accrual

This study matches entries in ClinicalTrials.gov for cancer drug trials at initiation of the trial with later entries and with journal reports of the trials to assess modifications in trial design, external factors associated with such modifications, and transparency in reporting them.

https://ift.tt/2UDQ40R